A detailed history of Invesco Ltd. transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 47,180 shares of SANA stock, worth $114,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47,180
Previous 46,284 1.94%
Holding current value
$114,175
Previous $252,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.76 - $6.86 $3,368 - $6,146
896 Added 1.94%
47,180 $196,000
Q2 2024

Aug 13, 2024

BUY
$5.23 - $10.44 $27,196 - $54,288
5,200 Added 12.66%
46,284 $252,000
Q1 2024

May 14, 2024

SELL
$4.2 - $11.27 $303,702 - $814,933
-72,310 Reduced 63.77%
41,084 $410,000
Q4 2023

Feb 12, 2024

BUY
$2.8 - $4.55 $23,741 - $38,579
8,479 Added 8.08%
113,394 $462,000
Q3 2023

Nov 13, 2023

BUY
$3.77 - $6.23 $5,213 - $8,616
1,383 Added 1.34%
104,915 $406,000
Q2 2023

Aug 11, 2023

SELL
$3.22 - $7.53 $10,851 - $25,376
-3,370 Reduced 3.15%
103,532 $617,000
Q1 2023

May 12, 2023

BUY
$3.11 - $4.92 $213,579 - $337,881
68,675 Added 179.65%
106,902 $349,000
Q4 2022

Feb 13, 2023

SELL
$3.19 - $6.46 $724 - $1,466
-227 Reduced 0.59%
38,227 $150,000
Q3 2022

Nov 14, 2022

SELL
$5.58 - $9.04 $3.97 Million - $6.43 Million
-711,744 Reduced 94.87%
38,454 $231,000
Q2 2022

Aug 15, 2022

BUY
$4.12 - $9.35 $2.94 Million - $6.67 Million
713,005 Added 1917.04%
750,198 $4.82 Million
Q1 2022

May 16, 2022

BUY
$5.24 - $15.58 $6,707 - $19,942
1,280 Added 3.56%
37,193 $307,000
Q4 2021

Feb 14, 2022

BUY
$15.18 - $23.15 $93,873 - $143,159
6,184 Added 20.8%
35,913 $556,000
Q3 2021

Nov 15, 2021

BUY
$16.29 - $25.88 $484,285 - $769,386
29,729 New
29,729 $669,000
Q2 2021

Aug 17, 2021

SELL
$16.65 - $32.14 $410,139 - $791,704
-24,633 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$23.04 - $43.5 $567,544 - $1.07 Million
24,633 New
24,633 $824,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $460M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.